Patents Assigned to Ludwig Institue for Cancer Research
  • Isolated nucleic acid molecules which encode T cell inducible factors (TIFS), the proteins encoded, and uses thereof
    Patent number: 6331613
    Abstract: The invention involves isolation of nucleic acid molecules, the expression of which are upregulated by interleukin-9. The amino acid sequences of the proteins which correspond to the nucleic acid molecules show some structural features of cytokines. In addition to the nucleic acid molecules and the proteins, various uses of the molecules are disclosed. The molecules are referred to as T cell inducible factors.
    Type: Grant
    Filed: October 18, 1999
    Date of Patent: December 18, 2001
    Assignee: Ludwig Institue for Cancer Research
    Inventors: Laure Dumoutier, Jamila Louhed, Jean-Christophe Renauld
  • Glioblastoma-derived angiogenesis inhibiting factor
    Patent number: 5990280
    Abstract: A glioblastoma-derived angiogenesis inhibiting factor is described. The material is induced in presence of wild type p53, but not by several mutated forms of p53. Various uses of the material are described.
    Type: Grant
    Filed: November 15, 1996
    Date of Patent: November 23, 1999
    Assignee: Ludwig Institue for Cancer Research
    Inventors: Erwin Van Meir, H.-J. Su Huang, Webster K Cavenee